Share

Children Who Are Sedentary May Have a Higher Risk of Heart Attack or Stroke Later in Life

Children who are physically inactive may have high cholesterol in early adulthood and subsequent heart health issues in their mid-forties, according to new research published in The Journal of Clinical Endocrinology & Metabolism. High cholesterol during childhood has been associated with early signs of heart disease when individuals reach their mid-twenties and an increased risk of...
Share

Pharm Fresh: What Pharmacological Solutions Could Play a Role in Preventing Diabetes?

EN_11_2023_COVER (002) For decades, physicians have maintained that type 2 diabetes could be delayed or even prevented altogether simply by modifying certain behaviors. Priyanka Majety, MD, talks to Endocrine News about pharmacological options that could help these patients, but lifestyle modifications are still crucial. As we enter National Diabetes Month and head toward World Diabetes Day on...
Share

Software Company Simplifies Glycemic Management for Clinicians and Pharmacists

In August, the insulin management software company Glytec unveiled the latest version of its Glucommander insulin dosing software to make it easier for providers, nurses, and pharmacists to offer optimal, personalized care. More than 300 hospitals in the U.S. use Glytec’s eGlycemic Management System® (eGMS®) for glycemic management for their patients. Glytec chief medical officer...
Share

Good Sports

winning with diabetes cover A new book spotlights athletes thriving with diabetes. In the new book, Winning with Diabetes: Inspiring Stories from Athletes to Help You Thrive, Rita R. Kalyani, MD, MHS; Mark D. Corriere, MD; and Patrick Smith have created an inspirational handbook that clinicians can share with their patients to help them overcome the challenges they may...
Share

Lonapegsomatropin Provides Height Improvements in Later Tanner Stages without Increase in Dose

Lonapegsomatropin, a once-weekly prodrug of somatropin, can help children in Tanner Stages 3-5 maintain consistent height standard deviation scores (SDS) without an increase in the mean dose, according to a study presented at ENDO 2023. Ascendis Pharma is marketing the drug as TransCon hGH. Researchers led by Paul Hofman, MD, FRACP, of the Liggins Institute...
Share

Children with Achondroplasia See Improved Annual Height Velocity with Investigational Prodrug

Children with achondroplasia (ACH), the most common form of hereditary short stature, experienced statistically significant improvements in their annual height velocity with the prodrug TransCon CNP, according to a study presented at ENDO 2023. Ascendis Pharma is investigating the drug in the Phase 2 ACcomplisH trial. Researchers led by Ravi Savarirayan, MBBS, FRACP, MD, of...